3644 results for «723»
3644 results
Typical chest pain: atypical angiogram
20 May 2026 – From EuroPCR 2026
This session addresses the management challenges posed by acute coronary syndromes when angiographic findings are ambiguous or atypical. It highlights the role of intravascular imaging in clarifying diagnoses and discusses recent insights from clinical cases and key studies such as DISCO and the latest NSTEMI EuroIntervention...
Imaging guided ultralow contrast PCI
20 May 2026 – From EuroPCR 2026
This session focuses on imaging-guided ultralow contrast PCI techniques designed to minimize contrast-induced nephropathy risk. It includes IVUS-guided strategies for distal left main bifurcation PCI, zero-contrast interventions in renal transplant patients, and precision stent placement without contrast use, emphasizing safety, precision, and frugality in contemporary PCI...
Registries and trials in TMVR
20 May 2026 – From EuroPCR 2026
This session provides an in-depth review of registries and clinical trials focused on transcatheter mitral valve replacement (TMVR). It presents data on annular and ventricular remodeling with the HighLife system, mid- to long-term valve performance, and innovations in transseptal TMVR using novel bioprostheses.
Mitral valve-in-valve, valve-in-ring, valve replacement: procedure challenges
20 May 2026 – From EuroPCR 2026
This session addresses procedural challenges in mitral valve interventions, including valve-in-valve, valve-in-ring, and valve replacement techniques. It covers lifetime management of patients with atrial fixated transcatheter mitral valve replacement (TMVR), approaches to recurrent mitral regurgitation, complex valve-in-valve cases, and hybrid strategies for valve-in-ring implantation, highlighting innovative...
When the angiogram shows no answer for your AMI patient: what's next?
20 May 2026 – From EuroPCR 2026
This session focuses on non-occlusive causes of acute coronary syndromes (ACS) when angiograms do not reveal clear pathology. It emphasizes the diagnostic value of intracoronary imaging for conditions such as MINOCA and spontaneous coronary artery dissection (SCAD), and discusses optimal treatment strategies and prognostic considerations.
Intracoronary imaging guidance in challenging PCI scenarios
20 May 2026 – From EuroPCR 2026
This session highlights the critical role of intracoronary imaging, particularly IVUS, in guiding complex percutaneous coronary interventions. It presents techniques such as IVUS-guided puncture of neo-ostia, stent implantation for ostial lesions, and innovative procedural methods like the Heart POTTER technique, underscoring the importance of precise imaging...
Stentless PCI, DCB and BVS in complex scenarios
20 May 2026 – From EuroPCR 2026
This session explores the use of stentless percutaneous coronary interventions (PCI) employing drug-coated balloons (DCB) and bioresorbable scaffolds (BVS) in complex coronary scenarios. Through detailed case discussions, it addresses decision-making processes, technical considerations, and practical tips for successfully completing PCI without permanent stenting.
Beyond first implant: valve-in-valve, redo and leaflet modification
20 May 2026 – From EuroPCR 2026
This session explores advanced transcatheter aortic valve therapies beyond the first implant, focusing on valve-in-valve, redo procedures, and leaflet modification techniques. Topics include bioprosthetic valve fracture, long-term outcomes from the DURA-ViV registry, simplified workflows for leaflet modification in redo-TAVI, and intravascular ultrasound evaluation of valve expansion...
DCB - Going beyond in-stent restenosis
20 May 2026 – From EuroPCR 2026
This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.
New tools for risk stratification in STEMI
20 May 2026 – From EuroPCR 2026
This session highlights novel tools and scores for risk stratification in ST-elevation myocardial infarction (STEMI) patients. It covers prognostic indices such as the index of microcirculatory resistance, the PREDICT-STEMI score, thrombus characteristics, sex differences in outcomes, renal impairment impacts, and benefits of complete revascularization strategies.
From entry to exit: managing arterial access for nurses and allied professionals
20 May 2026 – From EuroPCR 2026
This session focuses on arterial access management tailored for nurses and allied health professionals. It highlights key anatomical landmarks, demonstrates the purpose and use of common vascular closure devices through live manikin demonstrations, and discusses the essential role of nursing and allied staff in vascular access...
The structural bailout playbook: managing complications
21 May 2026 – From EuroPCR 2026
The session presents a practical structural bailout playbook focused on managing complex complications during structural heart interventions. It features challenging cases such as unusual atrial septal defect closure complications, navigation of a displaced patent ductus arteriosus stent in infants, percutaneous closure of mitral paravalvular leaks with...
Expect the unexpected when treating calcified lesions
20 May 2026 – From EuroPCR 2026
Addressing the unexpected challenges in treating calcified lesions, this session showcases novel combined strategies for managing distal small-vessel coronary perforations, alongside complex case studies involving perforations, dissections, and stent complications related to calcified nodules. It provides valuable insights into rescue techniques and complication management to improve...
Revascularisation in patients with multivessel disease and severe left ventricular impairment
21 May 2026 – From EuroPCR 2026
This session focuses on revascularisation strategies for patients with multivessel coronary disease complicated by severe left ventricular impairment. It emphasizes patient selection criteria, the crucial role of the heart team in decision-making, and optimization of percutaneous revascularisation outcomes. The content includes comprehensive case presentations and discussions...
AI adoption in the cathlab of tomorrow - Risk prediction applications
20 May 2026 – From EuroPCR 2026
This session delves into the adoption of artificial intelligence in the cath lab, focusing on clinically useful risk prediction models for coronary and structural interventions. It covers advanced AI-guided intravascular imaging, machine learning applications for adverse event prediction, and critical evaluation of model validation and clinical...
Advanced heart failure: left ventricular assist device as bridge to optimise guided-directed medical therapy
21 May 2026 – From EuroPCR 2026
This session explores advanced heart failure management with a focus on guided-directed medical therapy and the role of left ventricular assist devices (LVAD) as a bridge to therapy optimization. It discusses clinical, imaging, and biological parameters indicating LVAD use and highlights devices such as the Impella...
Complex endovascular and pulmonary interventions
20 May 2026 – From EuroPCR 2026
Explore advances in complex endovascular and pulmonary interventions, including the transformation of interventional labs into intelligent learning ecosystems, innovative approaches to peripheral and coronary CTOs, and novel therapies such as extravascular renal denervation and fixation catheters for acute pulmonary embolism.
Complex PCI - Best cases from PCR Global Interventional Academy - Part 2
21 May 2026 – From EuroPCR 2026
This session showcases best cases from the PCR Global Interventional Academy focusing on complex PCI scenarios. It addresses challenges such as managing ostial left anterior descending artery lesions, strategies for branch protection, implications of coronary involvement during TAVI, and future directions in complex coronary interventions. The...
First-in-human studies in cardiovascular devices: from first 10 patients to global innovation — How efficient early studies advance emerging technologies
20 May 2026 – From EuroPCR 2026
Understand the pivotal role of first-in-human studies in advancing cardiovascular device innovation through operational insights from early patient experiences. This session reviews cutting-edge technologies including percutaneous left ventricular assist devices, transcatheter leaflet augmentation, physiology-guided PCI, synchronized diaphragmatic stimulation, pulmonary artery denervation, and perspectives on translating early...
DCB as a key player in the management of complex coronary lesions
21 May 2026 – From EuroPCR 2026
This session highlights the pivotal role of drug-coated balloons (DCB) in managing complex coronary lesions. Experienced operators share their approaches to applying DCB in challenging clinical and anatomical settings, optimized by intravascular imaging guidance. The discussion includes insights from the LatamBif Registry and other series on...
